Previous studies have demonstrated the interaction of MTX and a variety of non-steroidal, anti-inflammatory drugs (NSAIDs) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
diarrhea
MTX
pyrexia
MTX
acute renal failure
MTX
vomiting
MTX
mucosal ulcerations
MTX
jaundice
MTX
pancytopenia
MTX
elevated liver transaminases
MTX